Profile
ABVX VRTX REGN ALNY SGEN ARGX
Company Name Abivax S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.30B $117.98B $59.32B $43.28B $43.15B $40.50B
Employees 0.07K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Marc M. P. de Garidel Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ABVX VRTX REGN ALNY SGEN ARGX
Quant Rating Score 1 2 4 1 3 4
Quant Rating Strong Sell Sell Buy Strong Sell Neutral Buy
Trading
ABVX VRTX REGN ALNY SGEN ARGX
Last Close $70.13 $366.54 $563 $438.93 $228.74 $661.83
High 52 $72.07 $516.74 $1201.76 $438.93 $228.74 $690.32
Low 52 $5.24 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -2.69 % -29.07 % -53.15 % 0 % 0 % -4.13 %
Price vs. 52 Week Low 1238.36 % 0 % 16.58 % 95.44 % 0 % 28.7 %
Total Return
ABVX VRTX REGN ALNY SGEN ARGX
1 Month Return 743.92 % -23.47 % 1.9 % 36.86 % 0 % 19.21 %
3 Month Return 945.16 % -13.75 % 6.67 % 74.77 % 0 % 20.41 %
6 Month Return 1013.17 % -21.9 % -20.65 % 58.92 % 0 % 2.35 %
9 Month Return 569.82 % -29.07 % -32.04 % 58.21 % 0 % 11.05 %
YTD Return 858.06 % -8.98 % -20.96 % 86.53 % 0 % 7.61 %
1 Year Return 526.72 % -21.75 % -50.23 % 62.86 % 0 % 23.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -242.99 % -3.53 % 4.37 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Profitability
ABVX VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 100 % 86.03 % 87.44 % 86.01 % 79.1 % 65.32 %
Return on Assets TTM -85.88 % -4.32 % 11.67 % -6.4 % -16.61 % 15.06 %
Return on Equity TTM -211 % -6.25 % 14.43 % -509.33 % -20.8 % 18.96 %
Return on Capital Employed TTM -166.71 % -3.89 % 11.12 % -3.68 % -21.46 % 5.04 %
Net Income Per EBT TTM 96.36 % 329.41 % 91.46 % 75.89 % 101.33 % 237.3 %
EBT Per Ebit TTM 98.63 % 40.44 % 126.92 % 308.03 % 98.26 % 147.38 %
EBIT Per Revenue TTM -1718.24 % -6.69 % 27.02 % -4.91 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -161.67 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Receivables Turnover TTM 0.69 6.15 2.53 5.62 3.91 1.91
Payables Turnover TTM 0.02 3.49 2.47 3.37 1.97 0.88
Inventory Turnover TTM - 1.14 0.56 5.01 0.96 2.21
Fixed Asset Turnover TTM 404.8 % 421.34 % 293.64 % 337.41 % 665.41 % 5009.77 %
Asset Turnover TTM 5.26 % 48.51 % 37.19 % 55.72 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -2.46 -3.82 45.13 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -2.47 -4.9 36.58 -0.58 -2.88 -1.09
Cash Per Share TTM 228.35 % 2413.86 % 7107.14 % 2024.29 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -1441.01 % -8.83 % 33.37 % -1.92 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.41 % 128.33 % 81.05 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -161.67 % -59.44 % 175.35 % -3.47 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -29.22 -93.78 15.43 -574.08 -81.26 -521.84
Price To Operating Cash Flows Ratio TTM -24.53 -120.39 12.38 -954.11 -93.1 -618.62
Price Cash Flow Ratio TTM -24.53 -120.39 12.38 -954.11 -93.1 -618.62
Income Statement (TTM)
ABVX VRTX REGN ALNY SGEN ARGX
Revenue $0.01B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.01B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 100% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0.17B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.18B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -2.8 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
ABVX VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.05B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.16B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.04B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.1B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.21B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
ABVX VRTX REGN ALNY SGEN ARGX
Net Income $-0.18B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.95
AARD Aardvark Therapeutics, Inc. Common Stock 11.99
ABCL AbCellera Biologics Inc. 4.25
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.26
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.36
ABPWW 0.0368
ABSI Absci Corporation 2.84
ABUS Arbutus Biopharma Corporation 3.4
ABVC ABVC BioPharma, Inc. 2.7
ACAD ACADIA Pharmaceuticals Inc. 24.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.621
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.5
ACIU AC Immune SA 2.14
ACLX Arcellx, Inc. 70.5
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 51.8997
BOUT Innovator IBD Breakout Opportunities ETF 2.56 36.79
SPEU SPDR Portfolio Europe ETF 0.001349 48.56
PINK Simplify Health Care ETF 1.98012 28.65
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 326.75
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 28335
Unlock